Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1995-05-25
2000-08-29
Hauda, Karen M.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 932, 4242771, 4353201, 435375, 435366, A61K 4800, C12N 1500, C12N 1563, C12N 500
Patent
active
061104582
ABSTRACT:
A method is provided for eliminating cancer cells from a population of cells containing cancer cells and noncancerous cells in vitro or in vivo comprising: (a) providing a mixture of noncancerous cells and cancer cells; (b) contacting the cancer cells with transgenic cancer cells comprising a foreign gene that renders the transgenic cancer cells susceptible to a therapeutic agent; and (c) contacting the transgenic cancer cells with an amount of said therapeutic agent effective to kill both the transgenic cancer cells and the cancer cells.
REFERENCES:
patent: 4938949 (1990-07-01), Borch et al.
patent: 5035878 (1991-07-01), Borch et al.
patent: 5262177 (1993-11-01), Brown et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5498410 (1996-03-01), Gleich
patent: 5580859 (1996-12-01), Felgner et al.
Anderson et al., Cold Spring Harbor Symp. Quant. Biol, 51, 1073 (1986).
Anderson et al., Science, 226, 401 (1984).
Asher et al., J. Immunol., 146, 3227 (1991).
Cotter et al., Anticancer Res., 10, 1153 (1990).
Drebin et al., Cell, 41, 695 (1985).
Eglitis et al., Biochem. Biophys. Res. Commun., 151, 201 (1988).
Eglitis et al., BioTechniques, 6, 608 (1988).
Fearon et al., Cell, 60, 397 (1990).
Fialkow et al., Biochem. Biophys. Acta, 458, 283 (1976).
Hanahan, Annu. Rev. Genet., 22, 479 (1988).
Holmes et al., Cancer Res., 33, 199 (1973).
Huber, Fed. Amer. Soc. Exper. Biol. J., 3, 5 (1989).
Land et al., Science, 222, 771 (1983).
Mann et al., Cell, 33, 153 (1983).
Moolton et al., Human Gene Therapy, 1, 125 (1990).
Moolton et al., J. Natl. Cancer Inst., 82, 297 (1990).
Moolton, Med. Hypotheses, 24, 43 (1987).
Moolton, Cancer Res., 46, 5276 (1986).
Nishiyama et al., J. Gen. Virol., 45, 227 (1979).
Rosenberg et al., New Eng. J. Med., 316, 889 (1987).
Russell et al., Immunol. Today, 11, 196 (1990).
Tsushimoto et al., Biochem. Biophys. Acta, 697, 14 (1982).
Wolff et al., Science, 247, 1465 (1990).
J. A. Eastham, et al., "Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer Models", Human Gene Therapy, 7, 515-523, (Jan., 1996).
A. A. Elshami, et al., "Treatment of Pleural Mesothelioma in an Immunocompetent Rat Model Utilizing Adenoviral Transfer of the Herpes Simplex Virus Thymidine Kinase Gene", Human Gene Therapy, 7, 141-148, (Jan., 1996).
D. Klatzmann, et al., "Gene Therapy for Metastatic Malignant Melanoma: Evalulation of Tolerance to Intratumoral Injection of Cells Producing Recombinant Retroviruses Carrying the Herpes Simplex Virus Type 1 Thymidine Kinase Gene, to be Followed by Ganciclovir Administration", Human Gene Therapy, 7, 255-267, (Jan., 1996).
A. J. P. E. Vincent, et al., "Herpes Simplex Virus Thymidine Kinase Gene Therapy for Rat Malignant Brain Tumors", Human Gene Therapy, 7, 197-205, (Jan., 1996).
Acsadi, G., et al., "Direct Gene Transfer and Expression into Rat Heart in Vivo", The New Biologist, vol. 3, No. 1, 71-81.
Chowdhury, J.R., et al., "Long-Term Improvement of Hypercholesterolemia After ex Vivo Gene Therapy in LDLR-Deficient Rabbits", Science, vol. 254, 1802-1805, (Dec. 20, 1991).
Hatzoglou, M., et al., "Hepatic Gene Transfer in Animals Using Retroviruses Containing the Promoter from the Gene for Phosphoenolpyruvate Carboxykinase", Journal of Biological Chemistry, 265, 17285-17293, (Oct., 1990).
Kay, M.A., et al., "Expression of human a1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes", Proceeds of the National Academy of Sciences of the USA, vol. 89, No. 1, 89-93.
Lin, H., et al., "Expression of Recombinant Genes in Myocardium in Vivo After Direct Injection of DNA", Circulation, vol. 82, No. 6, 2217-2221, (Dec., 1990).
Morgan, J.R., et al., "Expression of an Exogenous Growth Hormone Gene by Tranplantable Human Epidermal Cells", Science, vol. 237, 1476-1480, (Sep. 18, 1987).
Ogura, H., et al., "Implantation of Genetically Manipulated Fibroblasts into Mice as Antitumor a-Interferon Therapy", Cancer Research, vol. 50, 5102-5106, (Aug. 15, 1991).
Palella, T.D., et al., "Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector", Gene., vol. 80, 137-144, (1989).
Rosenberg, S.A., et al., "Gene Transfer Into Humans-Immunotherapy of Patients with Advanced Melanoma, Using Tumor Infiltrating Lymphocytes Modified by Retroviral Gene Transduction", The New England Journal of Medicine, 323, 570-578, (Aug., 1990).
Rosenfeld, M.A., et al., "Adenovirus-Mediated Transfer of a Recombinant a1-Antitrypsin Gene to the Lung Epithelium in Vivo", Science, vol. 252, 431-434, (Apr. 19, 1991).
Tani, K., et al., "Implantation of Fibroblasts Transfected with Human Granulocyte Colony-Stimulating Factor cDNA into Mice as a Model of Cytokine-Supplement Gene Therapy", Blood, vol. 74, No. 4, 1274-1280, (Sep. 1989).
van Beusechem, V.W., et al., "Expression of Human Adenosine Deaminase in Mice Transplanted with Hemopoietic Stem Cells Infected with Amphotropic Retroviruses", J. Exp. Med., vol. 172, 729-736, (Sep., 1990).
Wilson, J.M., et al., "Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes", Proc. Natl. Acad. Sci. USA, vol. 87, 8437-8441, (Nov., 1990).
Vieweg et al (1995) Cancer Invest. 13, 193-201.
Report and Recommend. of the Panel to Assess the NIH Investment in Res. on Gene Therap., Orken et al. Dec. 1995.
Mullen (1994) Pharmac. Ther. 63, 199-207.
Gansbacher et al. (1993) Cancer Invest. 11, 345-354.
David Barba, et al., "Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors", Proc. Natl. Acad. Sci. USA, 91, 4348-4352, (1994).
David Barba, et al., "Thymidine kinase-mediated killing of rat brain tumors", J. Neurosurg., 79, 729-735, (1993).
W. L. Bi, et al., Hum. Gene Ther., 4, 725, (1993).
Bernd Bonnekoh, et al., "Inhibition of Melanoma Growth by Adenoviral-mediated HSV thymidine kinase gene transfer in vivo", J. Invest. Derm., 104, 313-317, (1995).
Emiliana Borrelli, et al., "Targeting of an Inducible Toxic Phenotype in Animal Cells", Proc. Nat'l. Acad. Sci. USA, 85, 7572, (1988).
M. Caruso, et al., PNAS, 90, 7024, (1993).
S. H. Chen, et al., Can. Res., 56, 3758, (1996).
S. H. Chen, et al., PNAS, 91, 3054, (1994).
A. Colak, et al., Brain. Res., 691, 76, (1995).
Kenneth W. Culver, et al., "In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors", Science, 256, 1550-1552, (1992).
M. S. Dilber, et al., Blood, 88, 2192, (1995).
J. M. DiMaio, et al., Surgery, 116, 205, (1994).
Z. D. Ezzeddine, et al., "Selective Killing of Glioma Cells in Culture and in Vivo by Retrovirus Transfer of the Herpes Simplex Virus Thymidine Kinase Gene", New Biol., 3, 608-614, (1991).
S. M. Freeman, et al., Can. Letters, 92, 167-174, (1995).
Scott M. Freeman, et al., "In Situ Use of Suicide Gnees for Cancer Therapy", Seminars in Oncology, 23, 31-45, (1996).
S. M. Freeman, et al., "The Bystander Effect: Tumor regression when a fraction of the tumor mass is genetically modified", Cancer Res., 53, 5274-5284, (1993).
S. M. Freeman, et al., "The role of the immune system in the "bystander effect": new therapeutic approaches to cancer", Lancet, 349, 2-3, (1995).
Scott M. Freeman, et al., "Tumor Regression When a Fraction of the Tumor Mass Contains the HSV-TK Gene", Keystone Symposium on Gene Transfer, Replacement and Augmentation, Copper Mountain, Colorado, USA, Apr. 3-9, (1992).
S. Gagandeep, et al., Can. Gene Ther., 3, 83, (1996).
Bernd Gansbacher, et al., "Retroviral Vector-mediated v-Interferon Gene Transfer into Tumor Cells Generates Potent and Long Lasting Antitumor Immunity", Cancer Res., 50, 7820-7825, (1990).
Guenther Gastl, et al., "Retroviral Vector-mediated Lymphokine Gene Transfer into Human Renal Cancer Cells", Cancer Res., 52, 6229-6236, (1992).
Paul T. Golumbek, et al., "Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4", Science, 254, 713-716, (1991).
D. K. Hoganson, et al., Can. Res., 56, 1315, (1996)
Abraham George N.
Freeman Scott M.
Koeplin David
McCune Craig S.
Moolten Frederick L.
Hauda Karen M.
University of Rochester
LandOfFree
Cancer therapy utilizing ex vivo gene transduction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer therapy utilizing ex vivo gene transduction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer therapy utilizing ex vivo gene transduction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246669